| Urokinase can reduce heparin dose in patients with hypercoagulable states during hemodialysis | |
| Ren, Wanjun; Wei, Fang; Sha, Yabin; Wang, Qi; Xie, Lin | |
| 刊名 | Renal Failure
 |
| 2015 | |
| 卷号 | 37期号:4页码:646-651 |
| 关键词 | Anticoagulation combination treatment hemodialysis heparin urokinase |
| DOI | 10.3109/0886022X.2015.1010418 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4789096 |
| 专题 | 山东大学 |
| 作者单位 | Friendship Nephrology and Blood Purification Center, Jinan City Central Hospital, Shangdong University, Jinan, Shandong Province, 250013, Chi |
| 推荐引用方式 GB/T 7714 | Ren, Wanjun,Wei, Fang,Sha, Yabin,et al. Urokinase can reduce heparin dose in patients with hypercoagulable states during hemodialysis[J]. Renal Failure,2015,37(4):646-651. |
| APA | Ren, Wanjun,Wei, Fang,Sha, Yabin,Wang, Qi,&Xie, Lin.(2015).Urokinase can reduce heparin dose in patients with hypercoagulable states during hemodialysis.Renal Failure,37(4),646-651. |
| MLA | Ren, Wanjun,et al."Urokinase can reduce heparin dose in patients with hypercoagulable states during hemodialysis".Renal Failure 37.4(2015):646-651. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论